William Blair Has Pessimistic Outlook of USPH Q1 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Research analysts at William Blair dropped their Q1 2025 earnings per share estimates for shares of U.S. Physical Therapy in a research report issued on Tuesday, March 11th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $0.48 for the quarter, down from their prior estimate of $0.56. William Blair has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.77 EPS, Q4 2025 earnings at $0.76 EPS, FY2025 earnings at $2.73 EPS and FY2026 earnings at $3.05 EPS.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

A number of other research analysts have also weighed in on USPH. Barrington Research decreased their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Trading Down 0.4 %

Shares of USPH stock opened at $76.68 on Thursday. The stock’s fifty day moving average is $86.40 and its two-hundred day moving average is $87.36. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a market capitalization of $1.16 billion, a P/E ratio of 81.57, a PEG ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be issued a $0.45 dividend. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a yield of 2.35%. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s payout ratio is 97.83%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.70% of the stock is owned by insiders.

Institutional Trading of U.S. Physical Therapy

Several institutional investors and hedge funds have recently bought and sold shares of the stock. HighTower Advisors LLC raised its holdings in U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock valued at $429,000 after buying an additional 119 shares during the period. CBIZ Investment Advisory Services LLC raised its holdings in U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after buying an additional 122 shares during the period. Albert D Mason Inc. raised its holdings in U.S. Physical Therapy by 1.3% in the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock valued at $940,000 after buying an additional 139 shares during the period. Harbor Capital Advisors Inc. raised its holdings in U.S. Physical Therapy by 1.0% in the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock valued at $1,450,000 after buying an additional 156 shares during the period. Finally, Aquatic Capital Management LLC grew its position in U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock valued at $115,000 after acquiring an additional 198 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.